Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). - Moiseyev,V.S.; Poder,P.; Andrejevs,N. (Eur Heart J, 2002)